Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (5)
  • Fas/FasL
    (4)
  • Antibacterial
    (2)
  • Phosphatase
    (2)
  • Bcl-2 Family
    (1)
  • Calcium Channel
    (1)
  • Caspase
    (1)
  • ERK
    (1)
  • IDO
    (1)
  • Others
    (2)
TargetMol | Tags By Natures
  • Aralia
    (1)
  • Bupleurum
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (2)
  • Inflammation
    (2)
  • Nervous System
    (2)
  • Cardiovascular System
    (1)
  • Endocrine system
    (1)
  • Immune System
    (1)
  • Infection
    (1)
  • Reproductive system
    (1)
Filter
Search Result
Results for "

fas/fasl

" in TargetMol Product Catalog. Signaling Pathways : Fas/FasL
  • Inhibitors & Agonists
    10
    TargetMol | All_Pathways
  • Peptide Products
    2
    TargetMol | Peptide_Products
  • Natural Products
    3
    TargetMol | Natural_Products
  • Recombinant Protein
    6
    TargetMol | Recombinant_Protein
  • Antibody Products
    3
    TargetMol | Antibody_Products
  • Reference Standards
    2
    TargetMol | Standard_Products
  • Araloside A
    Chikusetsusaponin IV
    T4S02907518-22-1
    Araloside A (Chikusetsusaponin IV) might relieve cutaneous symptoms caused by excessive apoptotic cell death in the skin through the Fas/FasL pathway.
    • $31
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Kp7-6
    Kp76
    TP2594629628-53-1
    Kp7-6 is a Fas mimetic peptide that disrupts receptor complexes by simultaneously binding to Fas and FasL, thereby blocking downstream apoptotic signaling. Kp7-6 inhibits ERK1-2 phosphorylation, induces IκBα phosphorylation, and activates NF-κB. Kp7-6 suppresses the activation of caspase-8, caspase-3, and JNK, reduces human amylin-induced β-cell apoptosis, and decreases FasL-mediated lymphocyte cytotoxicity and apoptosis. In pancreatic neuroendocrine tumor models, Kp7-6 downregulates local FasL expression, increases CD8+Fas+ T-cell infiltration, and reduces tumor volume. Kp7-6 prevents concanavalin A-induced liver injury in mice and is applicable to research on type 2 diabetes, hepatitis, and pancreatic neuroendocrine tumors.
    • $48
    In Stock
    Size
    QTY
  • KR-33493
    KR-33494, KM-819
    TQ02201021497-97-1
    KR-33493 is a FAS-associated factor 1 (FAF1) inhibitor and can be used in studies about Parkinson's disease.
    • $34
    In Stock
    Size
    QTY
  • Marginatoxin
    TN44961422536-56-8
    Marginatoxin may be a promising chemopreventive agent for treating hepatocellular carcinoma, it induces human hepatoma BEL-7402 cells apoptosis in vitro and in vivo via activation of Fas/FasL-mediated apoptotic pathway.
    • $700
    Inquiry
    Size
    QTY
  • PaPE-1
    pathway Preferential Estrogen, PaPE1, PaPE 1
    T2023972107327-36-4
    PaPE-1 is a pathway-preferential estrogen that activates extracellular nuclear signaling pathways without affecting nuclear signaling pathways. It exerts anti-apoptotic effects by inhibiting Aβ-induced caspase activity and reducing chromatin condensation associated with apoptosis, thereby preventing neuronal cell death. Additionally, post-treatment with PaPE-1 decreases the mRNA expression of apoptosis-specific factors (such as Bax, Gsk3b, Fas, and Fasl) under Aβ influence, while upregulating Bcl2 expression.
    • Inquiry Price
    10-14 weeks
    Size
    QTY
  • Fenvalerate
    Phenvalerate, Evercide 2362
    T2541651630-58-1
    Fenvalerate (Evercide 2362) is a inhibitor of protein phosphatase 2B (calcineurin), a synthetic pyrethroid insecticide, and inhibits PP2B-Aα.High doses of Fenvalerate impair cognitive and behavioral development.Fenvalerate induces, through the Fas/FasL signaling pathway, the induction of Fenvalerate induces germ cell apoptosis in mouse testis through the Fas/FasL signaling pathway.
    • $40
    In Stock
    Size
    QTY
  • (Rac)-Indoximod
    T6026626988-72-7
    (Rac)-Indoximod (1-Methyl-DL-tryptophan) is a potent inhibitor of indoleamine 2,3-dioxygenase (IDO). Combined treatment with IFN-γ and (Rac)-Indoximod significantly suppresses the activity of α-SMA-expressing human cardiac myofibroblasts (hCMs) and promotes apoptosis by up-regulating the genes IRF-1, Fas, and FasL, effectively improving cardiac fibrosis[1].
    • Inquiry Price
    6-8 weeks
    Size
    QTY
  • Fenvalerate (Standard)
    TMSM-118251630-58-1
    Fenvalerate (Standard) is the standard substance of Fenvalerate, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Fenvalerate (Evercide 2362) is a inhibitor of protein phosphatase 2B (calcineurin), a synthetic pyrethroid insecticide, and inhibits PP2B-Aα.High doses of Fenvalerate impair cognitive and behavioral development.Fenvalerate induces, through the Fas/FasL signaling pathway, the induction of Fenvalerate induces germ cell apoptosis in mouse testis through the Fas/FasL signaling pathway.
    • $45
    7-10 days
    Size
    QTY
  • Araloside A (Standard)
    TMSM-25727518-22-1
    Araloside A (Standard) is a reference standard for research and analysis in studies involving Araloside A. Araloside A (Chikusetsusaponin IV) might relieve cutaneous symptoms caused by excessive apoptotic cell death in the skin through the Fas/FasL pathway.
    • $922
    7-10 days
    Size
    QTY
  • IP3RCYT
    TP3028
    IP3RCYT is an inhibitory peptide of IP3R that can prevent cytochrome C from binding with IP3R, with an IC50 of approximately 100 nM. It regulates intracellular calcium signaling. Additionally, IP3RCYT inhibits apoptosis in HeLa and Jurkat cells treated with staurosporine or membrane-bound Fas ligand (FasL).
    • Inquiry Price
    Inquiry
    Size
    QTY